Russell Investments Group
PRTK

Russell Investments Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Russell Investments Group’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-42,024
Closed -$295K – 3327
2021
Q1 		$295K Buy
42,024
+1,871
+5% +$13.5K ﹤0.01% 2724
2020
Q4 		$250K Buy
+40,153
New +$236K ﹤0.01% 2689
2018
Q1 		– Sell
-124,561
Closed -$2.26M – 3030
2017
Q4 		$2.26M Buy
124,561
+6,028
+5% +$126K ﹤0.01% 1756
2017
Q3 		$2.98M Buy
118,533
+54,746
+86% +$1.27M 0.01% 1554
2017
Q2 		$1.54M Buy
63,787
+52,818
+482% +$1.17M ﹤0.01% 1889
2017
Q1 		$211K Buy
+10,969
New +$173K ﹤0.01% 2688

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group's PRTK Position: Q2 2021 in Review

Russell Investments Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2021, closing a stake of 42,024 shares — an estimated $295K sold.

Russell Investments Group first reported a position in PRTK in Q1 2017 and held it in 6 quarters. The position peaked at $2.98M in Q3 2017. 116 funds tracked by Wall St. Rank hold PRTK as of Q2 2021.

  • Russell Investments Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 42,024 Paratek Pharmaceuticals, Inc. shares in Q2 2021, an estimated $295K.
  • Russell Investments Group first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2017 and held it in 6 quarters.
  • Russell Investments Group's Paratek Pharmaceuticals, Inc. position peaked at $2.98M in Q3 2017.
  • 116 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.